Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Grant of Options
Investegate announcements from MaxCyte, Inc., Grant of Options
Stay updated with breaking news from Amanda Murphy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from MaxCyte, Inc., Grant of Options
MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing News provided by Share this article Share this article GAITHERSBURG, Md., July 12, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering, today announced the public filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the " SEC") relating to a proposed dual listing of its shares of common stock on the Nasdaq Global Market (" Nasdaq") under the symbol "MXCT." As part of the pro...
Share this article Share this article GAITHERSBURG, Md., July 12, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT) (LSE: MXCN), a leading provider of platform technologies for cell engineering (" MaxCyte" or the " Company"), today announced the public filing of a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed dual-listing and public offering of shares of common stock on the Nasdaq Stock Market (the "offering"). The registration statement included a proposed change to the board of directors as well as unaudited financial information w...
Highly-technical testimony highlights fourth day of Amie Wright murder trial as trial will resume Monday morning
In the third day of Amie Wright's jury trial, medical professionals testified about Annalise Murphy's condition, remarking it was clear she was sick.